Skip to Main Content

Paper Details

Loss of SLCO1B3 drives taxane resistance in prostate cancer.
Br J Cancer
42
2016
Author NameAffiliation
Ren?? B??ttcherErasmus MC Cancer Institute, Erasmus University Medical Center
Ren?? B??ttcher
Alice A GibsonDivision of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University
Alex SparreboomDivision of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University
Ronald de WitErasmus MC Cancer Institute, Erasmus University Medical Center
  • 1 - 5

Datasets

Release 1.2